3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
37
Pancreatic Neoplasms
19
Stomach Neoplasms
16
Colonic Neoplasms
12
Carcinoma, Non-Small-Cell Lung
11
Burkitt Lymphoma
11
Adenocarcinoma Of Esophagus
11
Rectal Neoplasms
10
Neoplasm Metastasis
10
Esophageal Neoplasms
10
Neoplasms
9
Adenocarcinoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Leukemia, Biphenotypic, Acute
5
Cholangiocarcinoma
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Lung Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Advanced Solid Tumors
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Myelodysplastic Syndromes
2
Down Syndrome
2
Colorectal Adenocarcinoma
2
Carcinoma, Renal Cell
2
Interventions
Cyclophosphamide
28
Rituximab
24
fludarabine
16
fludarabine phosphate
12
Specimen Handling
12
ibrutinib
10
Magnetic Resonance Spectroscopy
10
obinutuzumab
9
Prednisone
8
Lenalidomide
8
Doxorubicin
8
Biopsy
8
polatuzumab vedotin
7
X-Rays
7
Phantoms, Imaging
7
Mycophenolic Acid
7
tocilizumab
6
pirtobrutinib
6
Whole-Body Irradiation
6
Vincristine
6
venetoclax
5
glofitamab
5
Nuclear Medicine Department, Hospital
5
Nivolumab
5
Gemcitabine
5
Etoposide
5
Busulfan
5
Bendamustine Hydrochloride
5
tazemetostat
4
pembrolizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
Leucovorin
×
90 days
×
Clear all
No trials found.